InvestorsHub Logo
Followers 47
Posts 6423
Boards Moderated 0
Alias Born 06/17/2009

Re: attilathehunt post# 100423

Tuesday, 04/11/2017 6:33:09 AM

Tuesday, April 11, 2017 6:33:09 AM

Post# of 473980
Attila, if it is #2, then Biogen will have a lot of egg on its face since it terminated two/three other agreements on seemingly compatible (might not be the right word) add-ons to its MS drug program before it jumped into the MSA with Anavex, after paying hundreds of millions, I believe. Lots of explaining to its s/holders if there is no HIT with Anavex.

IMO - Biogen had a very good idea of the potential end results. What might be happening behind the scenes is the preparation of patent applications of its drugs in combo with 2-73 while both companies await the financial structure approval by the Anavex s/holders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News